Hyder Arastu
Papers
2
Total Citations
7
H-Index
2
About
Hyder Arastu is a researcher whose work centers on improving the precision of lung cancer treatments, particularly through the intersection of interventional pulmonology and radiation oncology. His primary research focus is on enhancing respiratory motion tracking for stereotactic ablative radiotherapy (SABR), a critical treatment for patients with early-stage non-small cell lung cancer who are not surgical candidates. Arastu’s major contribution lies in developing a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (ENB). This innovation directly addresses the challenge of continuous tumor motion within the lungs, enabling more accurate targeting and delivery of radiation. His most cited paper, "Improved respiratory motion tracking through a novel fiducial marker placement guidance system during ENB" (2019), has garnered 5 citations, while a related 2017 work has 2 citations. Though his citation counts are modest, these publications represent foundational steps in a niche but clinically vital area. Arastu’s work is notable for its translational potential, aiming to improve outcomes for lung cancer patients by reducing treatment margins and minimizing damage to healthy tissue. His research is particularly relevant for students and clinicians interested in the convergence of advanced bronchoscopic techniques and precision radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2